NEW YORK — A patient enrolled in a long-term study of Pfizer’s hemophilia drug Hympavzi has died after experiencing serious side effects, the company said. Pfizer confirmed the patient died on Dec.NEW YORK — A patient enrolled in a long-term study of Pfizer’s hemophilia drug Hympavzi has died after experiencing serious side effects, the company said. Pfizer confirmed the patient died on Dec.
Pfizer says patient in hemophilia drug study died after serious side effects
